MITOXANTRONE

MITOXANTRONE was reported 6289 times

MITOXANTRONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MYELOBLAST PERCENTAGE DECREASED 7 0.5833
1 HAEMORRHAGIC ADRENAL INFARCTION 6 0.3750
2 HYPERTENSIVE HYDROCEPHALUS 6 0.2609
3 RUNX1 GENE MUTATION 4 0.2500
4 GRANULICATELLA INFECTION 10 0.2381
5 AMELOBLASTOMA 12 0.2264
6 CENTRAL NERVOUS SYSTEM ENTEROVIRAL INFECTION 3 0.1304
7 ACUTE PROMYELOCYTIC LEUKAEMIA DIFFERENTIATION SYNDROME 23 0.1106
8 GENOTOXICITY 4 0.1053
9 REFRACTORY ANAEMIA WITH RINGED SIDEROBLASTS 4 0.0909
10 RETINOIC ACID SYNDROME 15 0.0872
11 RIGHT VENTRICULAR EJECTION FRACTION DECREASED 4 0.0851
12 HEPATOSPLENIC CANDIDIASIS 12 0.0816
13 ACUTE PROMYELOCYTIC LEUKAEMIA 83 0.0807
14 STOMATOCOCCAL INFECTION 10 0.0806
15 LINEAGE SWITCH LEUKAEMIA 4 0.0755
16 GALLBLADDER ADENOCARCINOMA 5 0.0704
17 REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA 7 0.0686
18 MANTLE CELL LYMPHOMA STAGE IV 4 0.0667
19 RETINAL INFILTRATES 4 0.0656
20 HAEMORRHAGIC PNEUMONIA 4 0.0645
21 SEPTAL PANNICULITIS 5 0.0625
22 FOLLICULAR LYMPHOMA RECURRENT 5 0.0625
23 ASPIRATION BONE MARROW ABNORMAL 8 0.0593
24 CHROMOSOMAL MUTATION 4 0.0588
25 ACUTE MYELOID LEUKAEMIA REFRACTORY 10 0.0581
26 PARASPINAL ABSCESS 9 0.0581
27 ANTITHROMBIN III DEFICIENCY 5 0.0562
28 CLOSTRIDIUM BACTERAEMIA 12 0.0561
29 ALLOGENIC BONE MARROW TRANSPLANTATION THERAPY 3 0.0556
30 NON-HODGKIN'S LYMPHOMA RECURRENT 5 0.0543
31 T-CELL PROLYMPHOCYTIC LEUKAEMIA 5 0.0538
32 ABDOMINAL WALL WOUND 8 0.0519
33 ABSCESS FUNGAL 9 0.0514
34 ACUTE MONOCYTIC LEUKAEMIA 9 0.0495
35 HIGH-GRADE B-CELL LYMPHOMA 9 0.0481
36 CHRONIC LYMPHOCYTIC LEUKAEMIA TRANSFORMATION 10 0.0478
37 ACUTE LYMPHOCYTIC LEUKAEMIA REFRACTORY 6 0.0444
38 ACUTE MYELOMONOCYTIC LEUKAEMIA 11 0.0437
39 DYSTROPHIC CALCIFICATION 5 0.0435
40 LEUKAEMIC INFILTRATION 6 0.0429
41 REFRACTORY ANAEMIA WITH AN EXCESS OF BLASTS 13 0.0415
42 TREATMENT RELATED SECONDARY MALIGNANCY 8 0.0394
43 CLONAL EVOLUTION 4 0.0385
44 CHLOROMA 16 0.0379
45 CHROMOSOMAL DELETION 6 0.0377
46 HAEMATOPOIETIC NEOPLASM 7 0.0372
47 LEUKAEMIA RECURRENT 62 0.0366
48 LYMPHOMA TRANSFORMATION 13 0.0361
49 LOWER RESPIRATORY TRACT INFECTION FUNGAL 14 0.0360
50 CEREBRAL FUNGAL INFECTION 10 0.0353
51 IDIOPATHIC PNEUMONIA SYNDROME 10 0.0336
52 MINIMAL RESIDUAL DISEASE 16 0.0331
53 RESTRICTIVE CARDIOMYOPATHY 10 0.0330
54 LEUKAEMIA CUTIS 5 0.0325
55 GASTROENTERITIS STAPHYLOCOCCAL 5 0.0318
56 CHOLANGITIS INFECTIVE 8 0.0301
57 LARGE GRANULAR LYMPHOCYTOSIS 10 0.0298
58 T-CELL TYPE ACUTE LEUKAEMIA 6 0.0294
59 CHROMOSOME ABNORMALITY 4 0.0290
60 ACUTE MYELOID LEUKAEMIA RECURRENT 61 0.0284
61 DISSEMINATED MUCORMYCOSIS 11 0.0279
62 RESPIRATORY TRACT INFECTION FUNGAL 14 0.0265
63 PRIMARY HYPOGONADISM 4 0.0255
64 GASTROENTERITIS ADENOVIRUS 4 0.0255
65 5Q MINUS SYNDROME 4 0.0250
66 DISSEMINATED TOXOPLASMOSIS 3 0.0250
67 NEUROMYELITIS OPTICA 8 0.0240
68 CEREBELLAR TUMOUR 3 0.0238
69 CHROMOSOME ANALYSIS ABNORMAL 6 0.0236
70 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 61 0.0236
71 HAEMOGLOBINAEMIA 4 0.0234
72 PERIPARTUM CARDIOMYOPATHY 4 0.0233
73 PIERRE ROBIN SYNDROME 5 0.0233
74 B PRECURSOR TYPE ACUTE LEUKAEMIA 9 0.0232
75 KLEBSIELLA SEPSIS 26 0.0231
76 BLOOD STEM CELL HARVEST FAILURE 3 0.0203
77 CHRONIC HEPATITIS 16 0.0198
78 BLOOD BETA-D-GLUCAN INCREASED 6 0.0195
79 ADENOVIRAL HAEMORRHAGIC CYSTITIS 4 0.0192
80 GEOTRICHUM INFECTION 4 0.0190
81 NEUTROPENIC COLITIS 39 0.0188
82 CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT 13 0.0187
83 FUNGAEMIA 28 0.0178
84 ACUTE MYELOID LEUKAEMIA 275 0.0176
85 RHINOCEREBRAL MUCORMYCOSIS 6 0.0173
86 SWEAT GLAND TUMOUR 4 0.0170
87 CYTOMEGALOVIRUS ANTIGEN POSITIVE 3 0.0164
88 BIFASCICULAR BLOCK 3 0.0160
89 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 15 0.0158
90 FUSARIUM INFECTION 11 0.0157
91 MYELODYSPLASTIC SYNDROME 220 0.0152
92 CYTOGENETIC ABNORMALITY 17 0.0151
93 RELAPSING-REMITTING MULTIPLE SCLEROSIS 13 0.0150
94 MUCORMYCOSIS 39 0.0150
95 SINUSITIS FUNGAL 12 0.0150
96 STENOTROPHOMONAS INFECTION 20 0.0147
97 FUNGAL SEPSIS 12 0.0144
98 VENOOCCLUSIVE LIVER DISEASE 69 0.0140
99 CYTOMEGALOVIRUS GASTROENTERITIS 3 0.0139
100 ENTEROCOCCAL SEPSIS 11 0.0136
101 MARROW HYPERPLASIA 9 0.0132
102 APOPTOSIS 4 0.0129
103 DEVICE RELATED BACTERAEMIA 4 0.0129
104 BACTERIAL SEPSIS 42 0.0129
105 DENTAL TREATMENT 3 0.0124
106 PARAKERATOSIS 4 0.0123
107 CNS VENTRICULITIS 4 0.0123
108 DIFFERENTIATION SYNDROME 9 0.0123
109 CHRONIC MYELOMONOCYTIC LEUKAEMIA 8 0.0121
110 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 11 0.0119
111 DELAYED PUBERTY 3 0.0118
112 MANTLE CELL LYMPHOMA RECURRENT 5 0.0115
113 CYTOTOXIC OEDEMA 3 0.0113
114 PNEUMATOSIS 5 0.0112
115 FEBRILE BONE MARROW APLASIA 47 0.0110
116 STREPTOCOCCAL BACTERAEMIA 12 0.0110
117 DYSBIOSIS 9 0.0110
118 CENTRAL LINE INFECTION 4 0.0108
119 ENGRAFT FAILURE 3 0.0105
120 BONE MARROW INFILTRATION 4 0.0103
121 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 22 0.0103
122 PSEUDOMONAL SEPSIS 18 0.0103
123 APLASIA 20 0.0102
124 ACUTE LYMPHOCYTIC LEUKAEMIA 28 0.0099
125 UREAPLASMA INFECTION 4 0.0098
126 PROSTATE CANCER RECURRENT 6 0.0097
127 DELUSIONAL DISORDER, PERSECUTORY TYPE 4 0.0095
128 SECOND PRIMARY MALIGNANCY 78 0.0094
129 STEATOHEPATITIS 5 0.0093
130 CYTOMEGALOVIRUS CHORIORETINITIS 18 0.0092
131 B-CELL LYMPHOMA RECURRENT 5 0.0092
132 ASPERGILLOSIS 12 0.0092
133 FOLLICULAR LYMPHOMA 8 0.0091
134 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 20 0.0091
135 BLAST CELL CRISIS 3 0.0090
136 PULMONARY MYCOSIS 7 0.0090
137 FEBRILE NEUTROPENIA 596 0.0090
138 CANDIDA SEPSIS 8 0.0089
139 HEART TRANSPLANT 8 0.0088
140 STEM CELL TRANSPLANT 22 0.0088
141 PNEUMONIA KLEBSIELLA 16 0.0087
142 HAEMATOTOXICITY 82 0.0086
143 GRAFT VERSUS HOST DISEASE IN SKIN 19 0.0086
144 ESCHERICHIA BACTERAEMIA 20 0.0085
145 DISSEMINATED ASPERGILLOSIS 4 0.0085
146 PNEUMONIA FUNGAL 33 0.0084
147 COMPLICATIONS OF BONE MARROW TRANSPLANT 3 0.0083
148 HEMIANOPIA HOMONYMOUS 6 0.0082
149 CYSTITIS HAEMORRHAGIC 33 0.0082
150 CEREBRAL ASPERGILLOSIS 5 0.0081
151 BRONCHOPULMONARY ASPERGILLOSIS 63 0.0081
152 ACUTE LEUKAEMIA 13 0.0080
153 STRONGYLOIDIASIS 13 0.0080
154 MYELOID LEUKAEMIA 4 0.0080
155 AZOOSPERMIA 3 0.0078
156 PNEUMONIA NECROTISING 5 0.0077
157 ENTEROCOCCUS TEST POSITIVE 5 0.0077
158 CENTRAL NERVOUS SYSTEM LEUKAEMIA 3 0.0076
159 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 5 0.0076
160 RETROPERITONEAL LYMPHADENOPATHY 4 0.0076
161 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 29 0.0076
162 VENOOCCLUSIVE DISEASE 19 0.0076
163 PULMONARY MUCORMYCOSIS 4 0.0076
164 MYELOPROLIFERATIVE NEOPLASM 5 0.0075
165 PNEUMOCYSTIS JIROVECII INFECTION 9 0.0075
166 OVARIAN FAILURE 4 0.0075
167 CRANIAL NERVE DISORDER 5 0.0072
168 ASPERGILLUS INFECTION 46 0.0070
169 HEPATITIS E 11 0.0070
170 JC VIRUS INFECTION 11 0.0069
171 SYSTEMIC MYCOSIS 8 0.0068
172 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 4 0.0068
173 ENGRAFTMENT SYNDROME 4 0.0068
174 ALVEOLAR PROTEINOSIS 4 0.0068
175 STREPTOCOCCAL SEPSIS 8 0.0067
176 HISTIOCYTOSIS HAEMATOPHAGIC 20 0.0067
177 KLEBSIELLA INFECTION 34 0.0067
178 GRAFT VERSUS HOST DISEASE 48 0.0067
179 GINGIVAL ULCERATION 5 0.0066
180 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 18 0.0065
181 BLAST CRISIS IN MYELOGENOUS LEUKAEMIA 8 0.0065
182 NEOPLASM RECURRENCE 22 0.0065
183 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 53 0.0064
184 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 9 0.0064
185 MEGACOLON 10 0.0064
186 HYPERAMMONAEMIC ENCEPHALOPATHY 11 0.0063
187 CARDIOTOXICITY 56 0.0063
188 ANAEMIA NEONATAL 3 0.0062
189 BONE DEBRIDEMENT 3 0.0062
190 ENTEROCOCCAL INFECTION 30 0.0062
191 JUGULAR VEIN THROMBOSIS 11 0.0062
192 RETINAL DEGENERATION 8 0.0062
193 BONE MARROW DEPRESSION 6 0.0061
194 BONE MARROW FAILURE 125 0.0061
195 CSF TEST ABNORMAL 3 0.0060
196 SECONDARY IMMUNODEFICIENCY 7 0.0058
197 APLASTIC ANAEMIA 30 0.0057
198 BLAST CELL COUNT INCREASED 6 0.0057
199 ENTEROCOCCAL BACTERAEMIA 6 0.0057
200 LYMPHOCYTOSIS 12 0.0056
201 VASOGENIC CEREBRAL OEDEMA 4 0.0056
202 GENE MUTATION 11 0.0056
203 PORTAL HYPERTENSION 17 0.0055
204 CHRONIC MYELOID LEUKAEMIA 25 0.0054
205 NON-HODGKIN'S LYMPHOMA 7 0.0053
206 SUBILEUS 11 0.0053
207 KLEBSIELLA BACTERAEMIA 5 0.0053
208 VITH NERVE PARALYSIS 6 0.0053
209 AORTIC CALCIFICATION 3 0.0052
210 ASEPTIC NECROSIS BONE 4 0.0051
211 HYPERPHOSPHATAEMIA 11 0.0051
212 STAPHYLOCOCCAL SEPSIS 25 0.0051
213 PNEUMONIA MYCOPLASMAL 4 0.0050
214 ACUTE GRAFT VERSUS HOST DISEASE 23 0.0050
215 HYPOGAMMAGLOBULINAEMIA 33 0.0050
216 SOFT TISSUE INFECTION 9 0.0049
217 MULTIPLE-DRUG RESISTANCE 15 0.0048
218 ESCHERICHIA SEPSIS 14 0.0048
219 VENA CAVA THROMBOSIS 8 0.0048
220 EXPANDED DISABILITY STATUS SCALE SCORE INCREASED 6 0.0048
221 SEPTIC EMBOLUS 4 0.0048
222 BENIGN INTRACRANIAL HYPERTENSION 6 0.0048
223 HYPOPERFUSION 5 0.0048
224 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 11 0.0047
225 PSEUDOMONAL BACTERAEMIA 4 0.0047
226 BACTERAEMIA 55 0.0046
227 PSEUDOMONAS INFECTION 38 0.0044
228 MUCOSAL INFLAMMATION 116 0.0044
229 PRIMARY SEQUESTRUM 4 0.0044
230 EXTENSOR PLANTAR RESPONSE 4 0.0043
231 PREMATURE MENOPAUSE 4 0.0043
232 BONE MARROW TOXICITY 5 0.0042
233 PNEUMONIA INFLUENZAL 5 0.0042
234 NEUTROPENIC SEPSIS 30 0.0042
235 NEUTROPENIC INFECTION 4 0.0042
236 ACTINOMYCOSIS 4 0.0042
237 PNEUMONIA CYTOMEGALOVIRAL 8 0.0041
238 ESCHAR 3 0.0041
239 CONTINUOUS HAEMODIAFILTRATION 4 0.0041
240 CONGESTIVE CARDIOMYOPATHY 17 0.0041
241 AMINO ACID LEVEL INCREASED 3 0.0040
242 DIFFUSE LARGE B-CELL LYMPHOMA 31 0.0040
243 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 5 0.0040
244 SYSTEMIC CANDIDA 10 0.0040
245 DILATED CARDIOMYOPATHY 4 0.0040
246 STEROID WITHDRAWAL SYNDROME 4 0.0039
247 CYTOMEGALOVIRUS COLITIS 9 0.0039
248 CYTOMEGALOVIRUS ENTEROCOLITIS 3 0.0039
249 CYTOMEGALOVIRUS VIRAEMIA 17 0.0038
250 ENDOCARDITIS BACTERIAL 3 0.0038
251 DIARRHOEA INFECTIOUS 3 0.0038
252 BLOOD FIBRINOGEN INCREASED 3 0.0038
253 GUILLAIN-BARRE SYNDROME 18 0.0037
254 HUMAN HERPESVIRUS 6 INFECTION 7 0.0037
255 HAEMORRHAGIC DISORDER 4 0.0037
256 HEPATITIS B 22 0.0036
257 PANCYTOPENIA 204 0.0036
258 ESCHERICHIA INFECTION 30 0.0036
259 PERIODONTAL DISEASE 5 0.0036
260 MALIGNANT PLEURAL EFFUSION 6 0.0036
261 SEPTIC SHOCK 153 0.0035
262 LEFT VENTRICULAR FAILURE 12 0.0035
263 HORMONE-REFRACTORY PROSTATE CANCER 4 0.0034
264 CHRONIC GRAFT VERSUS HOST DISEASE 12 0.0033
265 CARDIOMYOPATHY 49 0.0033
266 SMALL CELL LUNG CANCER 5 0.0033
267 VENOUS THROMBOSIS 13 0.0033
268 MYELOFIBROSIS 10 0.0033
269 VARICES OESOPHAGEAL 10 0.0033
270 PROSTATE CANCER METASTATIC 11 0.0033
271 CYTOPENIA 40 0.0033
272 CEREBELLAR SYNDROME 7 0.0032
273 BONE MARROW TRANSPLANT 6 0.0032
274 GASTROINTESTINAL ULCER 7 0.0032
275 PLATELET TRANSFUSION 4 0.0031
276 PULMONARY HAEMORRHAGE 24 0.0031
277 MULTIPLE ORGAN DYSFUNCTION SYNDROME 86 0.0030
278 INTESTINAL DILATATION 4 0.0030
279 LUNG ADENOCARCINOMA 9 0.0030
280 BONE MARROW DISORDER 9 0.0030
281 ENTEROBACTER INFECTION 5 0.0030
282 GASTROINTESTINAL TOXICITY 14 0.0029
283 CAROTID ARTERIOSCLEROSIS 3 0.0029
284 ALVEOLITIS ALLERGIC 3 0.0029
285 HYPERTRIGLYCERIDAEMIA 17 0.0029
286 VITREOUS HAEMORRHAGE 8 0.0029
287 NEUTROPENIA 393 0.0029
288 ECHOCARDIOGRAM ABNORMAL 4 0.0029
289 DRUG RESISTANCE 73 0.0028
290 MYELITIS TRANSVERSE 4 0.0028
291 NECROTISING FASCIITIS 10 0.0028
292 HEPATITIS B REACTIVATION 9 0.0028
293 THROMBOCYTOPENIA 315 0.0028
294 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 21 0.0028
295 HAIR DISORDER 23 0.0028
296 BONE NEOPLASM 3 0.0028
297 PLATELET DISORDER 7 0.0028
298 NORMOCYTIC ANAEMIA 4 0.0027
299 LYMPHOMA 42 0.0027
300 CYTOMEGALOVIRUS INFECTION REACTIVATION 12 0.0027
301 OPPORTUNISTIC INFECTION 5 0.0027
302 HYPERBILIRUBINAEMIA 28 0.0027
303 CARDIAC HYPERTROPHY 3 0.0027
304 POTENTIATING DRUG INTERACTION 9 0.0027
305 BLOOD CULTURE POSITIVE 8 0.0027
306 CATHETER RELATED COMPLICATION 3 0.0027
307 CYTOMEGALOVIRUS INFECTION 44 0.0026
308 MYELOPATHY 5 0.0026
309 MANTLE CELL LYMPHOMA 4 0.0026
310 AREFLEXIA 7 0.0026
311 INVASIVE DUCTAL BREAST CARCINOMA 7 0.0026
312 EJECTION FRACTION DECREASED 40 0.0026
313 LEFT VENTRICULAR DYSFUNCTION 17 0.0025
314 PLEURITIC PAIN 7 0.0025
315 BILE DUCT CANCER 3 0.0025
316 METASTASIS 18 0.0025
317 PNEUMONIA VIRAL 8 0.0025
318 ESCHERICHIA TEST POSITIVE 3 0.0025
319 LUNG CONSOLIDATION 7 0.0025
320 CANDIDA INFECTION 42 0.0025
321 DISSEMINATED INTRAVASCULAR COAGULATION 35 0.0025
322 DISINHIBITION 4 0.0025
323 NEUTROPHIL COUNT ABNORMAL 7 0.0025
324 ENCEPHALITIS VIRAL 3 0.0025
325 SPLENIC RUPTURE 4 0.0024
326 CAPILLARY LEAK SYNDROME 5 0.0024
327 VACCINATION FAILURE 4 0.0024
328 PULMONARY TOXICITY 17 0.0024
329 TUMOUR LYSIS SYNDROME 21 0.0024
330 SEPSIS 266 0.0024
331 HEPATOTOXICITY 53 0.0024
332 DILATATION VENTRICULAR 5 0.0024
333 CEREBELLAR INFARCTION 4 0.0024
334 GASTROINTESTINAL INFECTION 21 0.0023
335 HEPATOSPLENOMEGALY 6 0.0023
336 LYMPHOPENIA 33 0.0023
337 LEUKAEMIA 22 0.0023
338 BLOOD CREATININE ABNORMAL 8 0.0023
339 CYTOKINE RELEASE SYNDROME 46 0.0023
340 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 3 0.0023
341 ENTEROCOLITIS 13 0.0022
342 PARAPARESIS 4 0.0022
343 CHOLESTATIC LIVER INJURY 5 0.0022
344 PARESIS 5 0.0022
345 PNEUMOCYSTIS JIROVECI PNEUMONIA 5 0.0022
346 NEUROTOXICITY 39 0.0022
347 PERIPHERAL SENSORY NEUROPATHY 13 0.0022
348 ABDOMINAL TENDERNESS 11 0.0022
349 CALCULUS BLADDER 3 0.0022
350 THERAPY PARTIAL RESPONDER 34 0.0022
351 LEUKOPENIA 109 0.0022
352 CENTRAL NERVOUS SYSTEM LYMPHOMA 3 0.0022
353 CLOSTRIDIUM DIFFICILE COLITIS 23 0.0022
354 NEUROLOGICAL DECOMPENSATION 5 0.0022
355 VITRITIS 4 0.0022
356 LUNG INFILTRATION 19 0.0021
357 APPENDICITIS 20 0.0021
358 FUNGAL INFECTION 71 0.0021
359 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 4 0.0021
360 URINARY TRACT OBSTRUCTION 5 0.0021
361 PULMONARY TUBERCULOSIS 9 0.0021
362 ADENOVIRUS INFECTION 6 0.0021
363 WOUND SECRETION 8 0.0020
364 ENTEROCOLITIS HAEMORRHAGIC 3 0.0020
365 HYPERNATRAEMIA 10 0.0020
366 HERPES SIMPLEX 13 0.0020
367 ERYTHEMA NODOSUM 7 0.0020
368 DEVICE RELATED SEPSIS 4 0.0020
369 MADAROSIS 23 0.0020
370 ATRIOVENTRICULAR BLOCK SECOND DEGREE 6 0.0020
371 RECURRENT CANCER 8 0.0020
372 CALCULUS URINARY 3 0.0019
373 METASTASES TO BONE 32 0.0019
374 QUADRIPLEGIA 4 0.0019
375 HAIR COLOUR CHANGES 24 0.0019
376 ELECTROCARDIOGRAM T WAVE ABNORMAL 3 0.0019
377 ACUTE RESPIRATORY DISTRESS SYNDROME 34 0.0019
378 MYELOSUPPRESSION 68 0.0019
379 LEUKOENCEPHALOPATHY 7 0.0019
380 MULTI-ORGAN FAILURE 32 0.0018
381 HEPATIC LESION 8 0.0018
382 ENCEPHALOPATHY 45 0.0018
383 METASTASES TO LIVER 32 0.0018
384 ELECTROCARDIOGRAM T WAVE INVERSION 4 0.0018
385 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 11 0.0018
386 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 9 0.0018
387 LUNG INFECTION 28 0.0018
388 HAIR TEXTURE ABNORMAL 24 0.0018
389 ILEUS PARALYTIC 8 0.0018
390 NEOPLASM PROGRESSION 62 0.0018
391 BK VIRUS INFECTION 6 0.0018
392 OLIGURIA 11 0.0018
393 SKIN TOXICITY 10 0.0018
394 RESPIRATORY FAILURE 128 0.0018
395 ENDOCARDITIS 9 0.0018
396 BRONCHOPNEUMONIA 6 0.0018
397 HEPATOMEGALY 17 0.0017
398 OVARIAN HYPERSTIMULATION SYNDROME 4 0.0017
399 DISEASE PROGRESSION 203 0.0017
400 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 3 0.0017
401 RETINAL HAEMORRHAGE 12 0.0017
402 TRANSPLANT 4 0.0017
403 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 16 0.0017
404 NON-SMALL CELL LUNG CANCER 8 0.0017
405 SUBARACHNOID HAEMORRHAGE 17 0.0017
406 TUMOUR MARKER INCREASED 8 0.0017
407 CONDUCTION DISORDER 3 0.0016
408 TRANSPLANT FAILURE 4 0.0016
409 PSYCHOLOGICAL TRAUMA 14 0.0016
410 SPLENOMEGALY 19 0.0016
411 DIFFUSE ALOPECIA 3 0.0016
412 CARDIAC DYSFUNCTION 6 0.0016
413 ACUTE RESPIRATORY FAILURE 31 0.0016
414 STAPHYLOCOCCAL INFECTION 53 0.0016
415 TOXIC ENCEPHALOPATHY 8 0.0016
416 BLOOD LACTATE DEHYDROGENASE INCREASED 25 0.0016
417 ABDOMINAL INFECTION 4 0.0016
418 EMBOLISM 13 0.0016
419 HEPATIC FAILURE 47 0.0016
420 PERICARDIAL EFFUSION 36 0.0016
421 AORTIC ARTERIOSCLEROSIS 4 0.0016
422 VENTRICULAR DYSFUNCTION 4 0.0015
423 DIPLEGIA 3 0.0015
424 THERAPY NON-RESPONDER 68 0.0015
425 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 5 0.0015
426 CARDIAC FAILURE ACUTE 10 0.0015
427 PNEUMOCYSTIS JIROVECII PNEUMONIA 15 0.0015
428 OSTEONECROSIS 49 0.0015
429 METASTASES TO SPINE 5 0.0015
430 B-CELL LYMPHOMA 5 0.0015
431 PURPURA 13 0.0015
432 CLUMSINESS 4 0.0015
433 DEMYELINATION 6 0.0015
434 HYPERKERATOSIS 8 0.0014
435 VIITH NERVE PARALYSIS 5 0.0014
436 THROMBOPHLEBITIS 5 0.0014
437 ACUTE PULMONARY OEDEMA 8 0.0014
438 CLOSTRIDIUM DIFFICILE INFECTION 31 0.0014
439 ANAEMIA MACROCYTIC 3 0.0014
440 DERMATITIS EXFOLIATIVE 7 0.0014
441 AGRANULOCYTOSIS 26 0.0014
442 CEREBRAL HAEMORRHAGE 50 0.0014
443 FACIAL PALSY 3 0.0014
444 PARAPLEGIA 4 0.0014
445 METASTASES TO LUNG 16 0.0014
446 TRICUSPID VALVE INCOMPETENCE 11 0.0014
447 EXPOSED BONE IN JAW 3 0.0014
448 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 7 0.0014
449 STAPHYLOCOCCAL BACTERAEMIA 6 0.0014
450 ABSCESS 22 0.0014
451 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 7 0.0014
452 ENDOMETRIAL CANCER 3 0.0014
453 COLITIS 51 0.0013
454 HAEMORRHAGE INTRACRANIAL 20 0.0013
455 PARTIAL SEIZURES 7 0.0013
456 DRUG TOXICITY 18 0.0013
457 IMMUNE THROMBOCYTOPENIA 6 0.0013
458 ACIDOSIS 10 0.0013
459 COMPRESSION FRACTURE 7 0.0013
460 LYMPHADENOPATHY 46 0.0013
461 DEVICE RELATED INFECTION 20 0.0013
462 BRAIN NATRIURETIC PEPTIDE INCREASED 4 0.0013
463 DIASTOLIC DYSFUNCTION 4 0.0013
464 BILIRUBIN CONJUGATED INCREASED 3 0.0013
465 OESOPHAGITIS 14 0.0013
466 EPSTEIN-BARR VIRUS INFECTION 8 0.0013
467 IRIDOCYCLITIS 4 0.0013
468 BONE DISORDER 23 0.0013
469 CARDIAC FAILURE 101 0.0013
470 WHITE BLOOD CELL COUNT ABNORMAL 8 0.0013
471 CANDIDIASIS 5 0.0012
472 PETECHIAE 13 0.0012
473 PANCREATITIS ACUTE 28 0.0012
474 INFECTION 180 0.0012
475 TRIGEMINAL NEURALGIA 5 0.0012
476 LOOSE TOOTH 4 0.0012
477 BLOOD IMMUNOGLOBULIN G DECREASED 3 0.0012
478 HYPERAMMONAEMIA 6 0.0012
479 PNEUMONIA BACTERIAL 11 0.0012
480 BLOOD BILIRUBIN INCREASED 32 0.0012
481 CLOSTRIDIAL INFECTION 4 0.0012
482 HEMIPARESIS 20 0.0012
483 CANCER PAIN 3 0.0012
484 PURULENT DISCHARGE 5 0.0012
485 INTESTINAL PERFORATION 13 0.0012
486 ASCITES 34 0.0012
487 ENCEPHALITIS 8 0.0012
488 PNEUMONITIS 31 0.0011
489 THROMBOTIC MICROANGIOPATHY 11 0.0011
490 NEUTROPHIL COUNT DECREASED 46 0.0011
491 ABDOMINAL MASS 3 0.0011
492 CHEILITIS 6 0.0011
493 TACHYPNOEA 15 0.0011
494 PLEURAL EFFUSION 67 0.0011
495 ENTERITIS 7 0.0011
496 VENTRICULAR ARRHYTHMIA 4 0.0011
497 HAEMOGLOBIN ABNORMAL 7 0.0011
498 CARDIOMEGALY 13 0.0011
499 CHRONIC LYMPHOCYTIC LEUKAEMIA 5 0.0011
500 SKIN MASS 7 0.0010
501 TOOTH EXTRACTION 13 0.0010
502 NEOPLASM 12 0.0010
503 SUBCUTANEOUS ABSCESS 5 0.0010
504 METASTASES TO LYMPH NODES 7 0.0010
505 COMA SCALE ABNORMAL 3 0.0010
506 DYSPNOEA AT REST 3 0.0010
507 TRANSAMINASES INCREASED 23 0.0010
508 RALES 6 0.0010
509 URINE OUTPUT DECREASED 9 0.0010
510 OESOPHAGEAL CANDIDIASIS 4 0.0010
511 PLATELET COUNT INCREASED 13 0.0010
512 PATHOGEN RESISTANCE 9 0.0010
513 NEPHROPATHY TOXIC 11 0.0010
514 PHLEBITIS 5 0.0010
515 CACHEXIA 5 0.0010
516 MALIGNANT NEOPLASM PROGRESSION 99 0.0010
517 BACTERIAL INFECTION 18 0.0010
518 HEPATIC FUNCTION ABNORMAL 36 0.0010
519 HEMIPLEGIA 8 0.0010
520 APHASIA 29 0.0010
521 SQUAMOUS CELL CARCINOMA 9 0.0010
522 BLOOD UREA INCREASED 16 0.0010
523 MOUTH HAEMORRHAGE 7 0.0010
524 HALLUCINATIONS, MIXED 4 0.0010
525 NYSTAGMUS 5 0.0009
526 ESCHERICHIA URINARY TRACT INFECTION 4 0.0009
527 AORTIC VALVE INCOMPETENCE 4 0.0009
528 LUNG NEOPLASM 4 0.0009
529 HYDROCEPHALUS 5 0.0009
530 HYPERTHERMIA 7 0.0009
531 JAW DISORDER 5 0.0009
532 DEAFNESS NEUROSENSORY 3 0.0009
533 ADRENAL INSUFFICIENCY 11 0.0009
534 TREATMENT FAILURE 75 0.0009
535 HYPOALBUMINAEMIA 7 0.0009
536 MENINGITIS 6 0.0009
537 NECROSIS 5 0.0009
538 OSTEONECROSIS OF JAW 22 0.0009
539 TOOTH ABSCESS 9 0.0009
540 MITRAL VALVE INCOMPETENCE 10 0.0009
541 STOMATITIS 53 0.0009
542 BLOOD DISORDER 7 0.0009
543 CENTRAL NERVOUS SYSTEM LESION 12 0.0009
544 ISCHAEMIA 4 0.0009
545 HERPES ZOSTER 50 0.0009
546 HERPES VIRUS INFECTION 5 0.0009
547 PULMONARY HYPERTENSION 18 0.0009
548 VASCULITIS 10 0.0009
549 METASTASES TO CENTRAL NERVOUS SYSTEM 11 0.0009
550 HYPOXIA 30 0.0009
551 SPINAL COLUMN STENOSIS 4 0.0008
552 RESPIRATORY TRACT INFECTION 22 0.0008
553 ANAEMIA 161 0.0008
554 CARDIAC TAMPONADE 4 0.0008
555 VIRAL UPPER RESPIRATORY TRACT INFECTION 4 0.0008
556 PULSE ABSENT 4 0.0008
557 ODYNOPHAGIA 5 0.0008
558 PROTHROMBIN TIME PROLONGED 5 0.0008
559 SHOCK 19 0.0008
560 C-REACTIVE PROTEIN INCREASED 30 0.0008
561 PYREXIA 285 0.0008
562 NO THERAPEUTIC RESPONSE 10 0.0008
563 ORAL DISORDER 6 0.0008
564 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 19 0.0008
565 HYPOPHOSPHATAEMIA 6 0.0008
566 COLON CANCER 12 0.0008
567 AMENORRHOEA 14 0.0008
568 SPINAL OSTEOARTHRITIS 7 0.0008
569 IMMUNOSUPPRESSION 7 0.0008
570 CATHETER SITE INFECTION 3 0.0008
571 HAEMODYNAMIC INSTABILITY 6 0.0008
572 MYOCARDITIS 9 0.0008
573 HYPOKALAEMIA 36 0.0008
574 DISEASE RECURRENCE 37 0.0008
575 OSTEOMYELITIS 14 0.0008
576 SKIN NECROSIS 4 0.0008
577 CARDIOGENIC SHOCK 11 0.0008
578 REFUSAL OF TREATMENT BY PATIENT 5 0.0008
579 ORAL CANDIDIASIS 10 0.0008
580 UROSEPSIS 7 0.0008
581 POLYNEUROPATHY 9 0.0008
582 BREAST CANCER METASTATIC 8 0.0007
583 JAUNDICE 20 0.0007
584 GINGIVITIS 4 0.0007
585 PULMONARY MASS 11 0.0007
586 SHOCK HAEMORRHAGIC 6 0.0007
587 SUPRAVENTRICULAR TACHYCARDIA 7 0.0007
588 RENAL FAILURE ACUTE 31 0.0007
589 PULMONARY FIBROSIS 14 0.0007
590 RESPIRATORY DISTRESS 20 0.0007
591 ATELECTASIS 7 0.0007
592 SINUS BRADYCARDIA 7 0.0007
593 COAGULOPATHY 12 0.0007
594 ORAL HERPES 14 0.0007
595 STATUS EPILEPTICUS 8 0.0007
596 PRODUCT USE IN UNAPPROVED INDICATION 175 0.0007
597 SINUS TACHYCARDIA 10 0.0007
598 CARDIAC FAILURE CHRONIC 3 0.0007
599 NEUROLOGICAL SYMPTOM 4 0.0007
600 LIVER DISORDER 31 0.0007
601 ANOREXIA 9 0.0007
602 ASPARTATE AMINOTRANSFERASE INCREASED 37 0.0007
603 BLOOD URIC ACID INCREASED 4 0.0007
604 PYELONEPHRITIS 6 0.0007
605 WHITE BLOOD CELL COUNT DECREASED 75 0.0007
606 HYPOKINESIA 10 0.0007
607 ALANINE AMINOTRANSFERASE INCREASED 42 0.0007
608 ATAXIA 8 0.0007
609 PNEUMONIA 217 0.0007
610 LEUKOCYTOSIS 12 0.0007
611 OPTIC NEURITIS 6 0.0007
612 HAEMATOCRIT DECREASED 13 0.0007
613 CELLULITIS 33 0.0007
614 LUNG DISORDER 32 0.0007
615 MUSCLE SPASTICITY 8 0.0007
616 BLOOD ALKALINE PHOSPHATASE INCREASED 16 0.0006
617 SKIN REACTION 9 0.0006
618 PLATELET COUNT DECREASED 68 0.0006
619 ARTERIOSCLEROSIS 6 0.0006
620 BRAIN OEDEMA 8 0.0006
621 HYPERGLYCAEMIA 23 0.0006
622 BLOOD ALBUMIN DECREASED 5 0.0006
623 ENDOMETRIOSIS 3 0.0006
624 PULMONARY OEDEMA 27 0.0006
625 CAESAREAN SECTION 7 0.0006
626 EMPHYSEMA 6 0.0006
627 DYSPHORIA 3 0.0006
628 MOTOR DYSFUNCTION 6 0.0006
629 CHOLECYSTITIS 7 0.0006
630 HYPERLIPIDAEMIA 7 0.0006
631 RASH MACULO-PAPULAR 13 0.0006
632 ELECTROCARDIOGRAM QT PROLONGED 21 0.0006
633 CEREBRAL ISCHAEMIA 3 0.0006
634 RESPIRATORY SYNCYTIAL VIRUS INFECTION 5 0.0006
635 PANCREATITIS 30 0.0006
636 SUDDEN DEATH 6 0.0006
637 HAEMOGLOBIN DECREASED 58 0.0006
638 LUNG NEOPLASM MALIGNANT 23 0.0006
639 BLOOD PRESSURE ABNORMAL 11 0.0006
640 HIDRADENITIS 5 0.0005
641 BLOOD GLUCOSE ABNORMAL 10 0.0005
642 MENTAL STATUS CHANGES 15 0.0005
643 HAEMOPTYSIS 15 0.0005
644 PERICARDITIS 9 0.0005
645 OFF LABEL USE 469 0.0005
646 ANGIOPATHY 3 0.0005
647 DIARRHOEA HAEMORRHAGIC 5 0.0005
648 HYDRONEPHROSIS 4 0.0005
649 PULMONARY CONGESTION 7 0.0005
650 CHOLECYSTITIS ACUTE 3 0.0005
651 HYPOCALCAEMIA 10 0.0005
652 MULTIPLE SCLEROSIS RELAPSE 36 0.0005
653 MATERNAL DRUGS AFFECTING FOETUS 4 0.0005
654 WHITE BLOOD CELL COUNT INCREASED 20 0.0005
655 RENAL FAILURE CHRONIC 4 0.0005
656 TORSADE DE POINTES 4 0.0005
657 COVID-19 PNEUMONIA 6 0.0005
658 DEEP VEIN THROMBOSIS 33 0.0005
659 BLOOD CREATININE INCREASED 33 0.0005
660 INFLAMMATION 26 0.0005
661 GINGIVAL PAIN 4 0.0005
662 GENERAL PHYSICAL HEALTH DETERIORATION 58 0.0005
663 PAIN IN JAW 14 0.0005
664 TACHYCARDIA 43 0.0005
665 HEPATIC STEATOSIS 9 0.0005
666 FLUID OVERLOAD 7 0.0005
667 EOSINOPHIL COUNT INCREASED 4 0.0005
668 IMMUNODEFICIENCY 7 0.0005
669 THERAPEUTIC RESPONSE DECREASED 28 0.0005
670 RENAL FAILURE 61 0.0005
671 DRUG INTERACTION 72 0.0005
672 ARTERIOSCLEROSIS CORONARY ARTERY 3 0.0005
673 LYMPHOCYTE COUNT DECREASED 8 0.0005
674 DELUSION 7 0.0005
675 CEREBRAL INFARCTION 11 0.0004
676 NERVOUS SYSTEM DISORDER 14 0.0004
677 MALIGNANT MELANOMA 6 0.0004
678 LIVER FUNCTION TEST ABNORMAL 13 0.0004
679 MALNUTRITION 5 0.0004
680 BREAST MASS 3 0.0004
681 SKIN INFECTION 5 0.0004
682 BRONCHIECTASIS 3 0.0004
683 BLOOD CALCIUM DECREASED 5 0.0004
684 BONE PAIN 26 0.0004
685 CHILLS 52 0.0004
686 GINGIVAL BLEEDING 6 0.0004
687 ACUTE HEPATIC FAILURE 6 0.0004
688 ECCHYMOSIS 3 0.0004
689 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 24 0.0004
690 GASTROINTESTINAL HAEMORRHAGE 36 0.0004
691 COORDINATION ABNORMAL 6 0.0004
692 DEPRESSED LEVEL OF CONSCIOUSNESS 17 0.0004
693 MOUTH ULCERATION 9 0.0004
694 HEPATIC CIRRHOSIS 8 0.0004
695 DUODENAL ULCER 3 0.0004
696 HEPATOCELLULAR INJURY 6 0.0004
697 DIVERTICULUM 3 0.0004
698 NEUROPATHY PERIPHERAL 40 0.0004
699 UPPER GASTROINTESTINAL HAEMORRHAGE 7 0.0004
700 SMALL INTESTINAL OBSTRUCTION 5 0.0004
701 HYPERCALCAEMIA 5 0.0004
702 GENERALISED OEDEMA 5 0.0004
703 DISORIENTATION 16 0.0004
704 ILEUS 5 0.0004
705 RESPIRATORY DISORDER 12 0.0004
706 TOXIC SKIN ERUPTION 4 0.0004
707 HAEMATEMESIS 10 0.0004
708 EPILEPSY 12 0.0004
709 HAEMORRHAGE 41 0.0004
710 URINARY RETENTION 13 0.0004
711 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 4 0.0004
712 HAEMATOMA 10 0.0004
713 DIPLOPIA 10 0.0004
714 ELECTROCARDIOGRAM ABNORMAL 3 0.0004
715 HAEMATURIA 13 0.0004
716 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 27 0.0004
717 HYPOTENSION 75 0.0004
718 SENSORY DISTURBANCE 6 0.0004
719 CARDIAC FAILURE CONGESTIVE 30 0.0004
720 ACUTE MYOCARDIAL INFARCTION 11 0.0004
721 OEDEMA 20 0.0004
722 DECUBITUS ULCER 3 0.0004
723 ASPIRATION 4 0.0004
724 PHOTOSENSITIVITY REACTION 6 0.0004
725 PROSTATIC SPECIFIC ANTIGEN INCREASED 5 0.0004
726 PRODUCT USE ISSUE 68 0.0004
727 GAMMA-GLUTAMYLTRANSFERASE INCREASED 8 0.0004
728 HYPOMAGNESAEMIA 5 0.0004
729 BRADYCARDIA 19 0.0004
730 PULMONARY EMBOLISM 34 0.0004
731 RENAL IMPAIRMENT 30 0.0004
732 CIRCULATORY COLLAPSE 6 0.0004
733 FACIAL PARALYSIS 3 0.0004
734 INTERSTITIAL LUNG DISEASE 17 0.0004
735 TOXICITY TO VARIOUS AGENTS 59 0.0003
736 SUBDURAL HAEMATOMA 5 0.0003
737 PARALYSIS 5 0.0003
738 ANURIA 3 0.0003
739 IMPAIRED QUALITY OF LIFE 5 0.0003
740 ALOPECIA 67 0.0003
741 DRUG ERUPTION 6 0.0003
742 DYSPHAGIA 32 0.0003
743 FACIAL PAIN 3 0.0003
744 PROSTATE CANCER 27 0.0003
745 CARDIO-RESPIRATORY ARREST 14 0.0003
746 MUSCLE RIGIDITY 4 0.0003
747 VISUAL ACUITY REDUCED 11 0.0003
748 INTENTIONAL PRODUCT USE ISSUE 29 0.0003
749 CORONARY ARTERY DISEASE 10 0.0003
750 OSTEOPENIA 5 0.0003
751 EXOSTOSIS 3 0.0003
752 ERYTHEMA MULTIFORME 3 0.0003
753 DRUG INEFFECTIVE 423 0.0003
754 DYSARTHRIA 12 0.0003
755 INTESTINAL OBSTRUCTION 12 0.0003
756 INCREASED APPETITE 6 0.0003
757 HEPATIC CYTOLYSIS 4 0.0003
758 ACUTE KIDNEY INJURY 48 0.0003
759 METABOLIC ACIDOSIS 10 0.0003
760 HIATUS HERNIA 4 0.0003
761 HAEMORRHOIDS 6 0.0003
762 INFUSION RELATED REACTION 20 0.0003
763 GASTROINTESTINAL DISORDER 27 0.0003
764 COGNITIVE DISORDER 14 0.0003
765 BRAIN INJURY 3 0.0003
766 CONTRAINDICATED PRODUCT ADMINISTERED 9 0.0003
767 FACE OEDEMA 5 0.0003
768 ARRHYTHMIA 14 0.0003
769 BODY TEMPERATURE INCREASED 6 0.0003
770 PERITONITIS 6 0.0003
771 ATRIAL FIBRILLATION 28 0.0003
772 LIVER INJURY 7 0.0003
773 HYPONATRAEMIA 16 0.0003
774 SKIN CANCER 6 0.0003
775 TOOTHACHE 5 0.0003
776 PELVIC PAIN 5 0.0003
777 GASTROENTERITIS 4 0.0003
778 HEPATITIS 7 0.0003
779 RESTLESSNESS 10 0.0003
780 COMA 13 0.0003
781 DENTAL CARIES 3 0.0003
782 VIRAL INFECTION 9 0.0003
783 NEOPLASM MALIGNANT 18 0.0003
784 CONJUNCTIVITIS 5 0.0003
785 ABDOMINAL DISTENSION 28 0.0003
786 CONFUSIONAL STATE 43 0.0003
787 PREMATURE BABY 8 0.0003
788 SINUSITIS 27 0.0003
789 CONVULSION 15 0.0003
790 CHOLESTASIS 5 0.0003
791 UPPER RESPIRATORY TRACT INFECTION 12 0.0003
792 EYELID OEDEMA 3 0.0003
793 ULCER 4 0.0003
794 PREMATURE DELIVERY 4 0.0003
795 MULTIPLE SCLEROSIS 12 0.0003
796 FULL BLOOD COUNT DECREASED 5 0.0002
797 NEURALGIA 6 0.0002
798 INTERNATIONAL NORMALISED RATIO INCREASED 7 0.0002
799 RED BLOOD CELL COUNT DECREASED 7 0.0002
800 CARDIAC ARREST 20 0.0002
801 PARAESTHESIA 38 0.0002
802 BLOOD PRESSURE DECREASED 16 0.0002
803 EPISTAXIS 18 0.0002
804 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 7 0.0002
805 PSYCHOTIC DISORDER 7 0.0002
806 HALLUCINATION, VISUAL 5 0.0002
807 URINARY INCONTINENCE 7 0.0002
808 BREAST CANCER 22 0.0002
809 BLOOD POTASSIUM DECREASED 7 0.0002
810 ANAPHYLACTIC SHOCK 6 0.0002
811 LOCAL SWELLING 4 0.0002
812 URINARY TRACT INFECTION 39 0.0002
813 COVID-19 40 0.0002
814 BLOOD TRIGLYCERIDES INCREASED 4 0.0002
815 EYE HAEMORRHAGE 3 0.0002
816 BLINDNESS 9 0.0002
817 HEPATIC ENZYME INCREASED 15 0.0002
818 RHABDOMYOLYSIS 9 0.0002
819 APHONIA 3 0.0002
820 CHOLELITHIASIS 7 0.0002
821 DIALYSIS 3 0.0002
822 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 11 0.0002
823 DEHYDRATION 28 0.0002
824 DEATH 175 0.0002
825 PRESCRIBED UNDERDOSE 4 0.0002
826 PNEUMONIA ASPIRATION 5 0.0002
827 SWELLING FACE 13 0.0002
828 HYPERKALAEMIA 7 0.0002
829 HEART RATE DECREASED 7 0.0002
830 ANAPHYLACTIC REACTION 11 0.0002
831 DYSPNOEA 112 0.0002
832 ABDOMINAL PAIN LOWER 5 0.0002
833 DRUG INTOLERANCE 19 0.0002
834 OXYGEN SATURATION DECREASED 11 0.0002
835 VOMITING 92 0.0002
836 HYPOPHAGIA 5 0.0002
837 CONDITION AGGRAVATED 59 0.0002
838 SKIN ULCER 5 0.0002
839 TOOTH LOSS 4 0.0002
840 CARDIAC DISORDER 18 0.0002
841 SEIZURE 22 0.0002
842 NIGHT SWEATS 6 0.0002
843 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
844 HYPERSENSITIVITY 34 0.0002
845 INTERVERTEBRAL DISC PROTRUSION 4 0.0002
846 IMPAIRED HEALING 6 0.0002
847 MELAENA 4 0.0002
848 OEDEMA PERIPHERAL 22 0.0002
849 STEVENS-JOHNSON SYNDROME 4 0.0002
850 MUSCULAR WEAKNESS 20 0.0002
851 LETHARGY 10 0.0002
852 MUSCLE TWITCHING 4 0.0002
853 PANCREATIC CARCINOMA 5 0.0002
854 FOETAL EXPOSURE DURING PREGNANCY 14 0.0002
855 ABDOMINAL PAIN 40 0.0002
856 ASTHENIA 64 0.0002
857 SYNCOPE 17 0.0002
858 DIARRHOEA 109 0.0002
859 DIABETIC KETOACIDOSIS 4 0.0002
860 PRESYNCOPE 4 0.0002
861 BALANCE DISORDER 14 0.0002
862 VISUAL IMPAIRMENT 20 0.0002
863 DYSPNOEA EXERTIONAL 6 0.0002
864 BACK PAIN 37 0.0002
865 EAR PAIN 3 0.0002
866 LOWER RESPIRATORY TRACT INFECTION 7 0.0002
867 CHOKING 3 0.0002
868 HYPOAESTHESIA 23 0.0002
869 MOBILITY DECREASED 11 0.0002
870 DEAFNESS 4 0.0002
871 MUSCULOSKELETAL PAIN 8 0.0002
872 SKIN DISCOLOURATION 7 0.0002
873 ANHEDONIA 4 0.0002
874 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
875 MALAISE 66 0.0002
876 FATIGUE 117 0.0002
877 COUGH 42 0.0001
878 BRONCHITIS 11 0.0001
879 HEADACHE 93 0.0001
880 LOSS OF CONSCIOUSNESS 19 0.0001
881 PALLOR 4 0.0001
882 PRODUCTIVE COUGH 7 0.0001
883 NAUSEA 116 0.0001
884 HALLUCINATION 11 0.0001
885 MATERNAL EXPOSURE DURING PREGNANCY 13 0.0001
886 SKIN LESION 4 0.0001
887 ABNORMAL DREAMS 4 0.0001
888 DERMATITIS 3 0.0001
889 DEMENTIA 4 0.0001
890 EYE PAIN 8 0.0001
891 OSTEOARTHRITIS 6 0.0001
892 HYPOACUSIS 6 0.0001
893 CHEST PAIN 25 0.0001
894 CHROMATURIA 3 0.0001
895 ERYTHEMA 27 0.0001
896 SKIN EXFOLIATION 11 0.0001
897 SWELLING 12 0.0001
898 DRUG-INDUCED LIVER INJURY 4 0.0001
899 HAEMATOCHEZIA 7 0.0001
900 ABNORMAL BEHAVIOUR 5 0.0001
901 CYSTITIS 4 0.0001
902 NECK PAIN 7 0.0001
903 DECREASED APPETITE 29 0.0001
904 DYSKINESIA 5 0.0001
905 RASH 53 0.0001
906 SKIN DISORDER 4 0.0001
907 BLADDER CANCER 7 0.0001
908 CARDIOVASCULAR DISORDER 3 0.0001
909 MYALGIA 20 0.0001
910 CATARACT 7 0.0001
911 HYPERTENSION 24 0.0001
912 THROMBOSIS 9 0.0001
913 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
914 DISTURBANCE IN ATTENTION 6 0.0001
915 PALPITATIONS 13 0.0001
916 CONSTIPATION 24 0.0001
917 ACCIDENTAL OVERDOSE 4 0.0001
918 AGITATION 8 0.0001
919 DYSURIA 4 0.0001
920 DIVERTICULITIS 3 0.0001
921 AMNESIA 7 0.0001
922 BLISTER 6 0.0001
923 CEREBROVASCULAR ACCIDENT 18 0.0001
924 WEIGHT DECREASED 29 0.0001
925 DYSPHONIA 6 0.0001
926 PLASMA CELL MYELOMA 4 0.0001
927 ANXIETY 29 0.0001
928 DEPRESSION 23 0.0001
929 INFLUENZA 11 0.0001
930 FLUID RETENTION 5 0.0001
931 MYOCARDIAL INFARCTION 17 0.0001
932 ECZEMA 5 0.0001
933 RECTAL HAEMORRHAGE 4 0.0001
934 DRUG EFFECT DECREASED 5 0.0001
935 PAIN 57 0.0001
936 RASH PRURITIC 5 0.0001
937 VAGINAL HAEMORRHAGE 4 0.0001
938 MUSCULOSKELETAL STIFFNESS 8 0.0001
939 EYE DISORDER 3 0.0001
940 HEART RATE INCREASED 9 0.0001
941 ARTHRITIS 7 0.0001
942 DRUG EXPOSURE DURING PREGNANCY 3 0.0001
943 RENAL DISORDER 4 0.0001
944 INFLUENZA LIKE ILLNESS 7 0.0001
945 RASH ERYTHEMATOUS 4 0.0001
946 DRUG EFFECT INCOMPLETE 3 0.0001
947 HYPOGLYCAEMIA 4 0.0001
948 DYSPEPSIA 8 0.0001
949 SOMNOLENCE 16 0.0001
950 DIABETES MELLITUS 6 0.0001
951 TREMOR 13 0.0001
952 FALL 26 0.0001
953 RHINORRHOEA 5 0.0001
954 DIZZINESS 38 0.0001
955 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
956 EMOTIONAL DISTRESS 9 0.0001
957 VISION BLURRED 10 0.0001
958 CONTUSION 7 0.0001
959 ARTHROPATHY 4 0.0001
960 GAIT DISTURBANCE 12 0.0001
961 HYPERHIDROSIS 8 0.0001
962 ARTHRALGIA 25 0.0001
963 CHEST DISCOMFORT 6 0.0001
964 WEIGHT INCREASED 13 0.0001
965 BURNING SENSATION 4 0.0001
966 INJURY 4 0.0001
967 DEPRESSED MOOD 3 0.0001
968 SLEEP DISORDER 4 0.0001
969 OROPHARYNGEAL PAIN 5 0.0001
970 URTICARIA 9 0.0001
971 MUSCLE SPASMS 9 0.0000
972 EXPOSURE DURING PREGNANCY 3 0.0000
973 DRUG WITHDRAWAL SYNDROME 4 0.0000
974 PAIN IN EXTREMITY 13 0.0000
975 MEMORY IMPAIRMENT 6 0.0000
976 ABDOMINAL DISCOMFORT 7 0.0000
977 FLUSHING 4 0.0000
978 DRUG DEPENDENCE 6 0.0000
979 COMPLETED SUICIDE 3 0.0000
980 INSOMNIA 9 0.0000
981 ADVERSE DRUG REACTION 3 0.0000
982 FEELING ABNORMAL 8 0.0000
983 NO ADVERSE EVENT 6 0.0000
984 BLOOD PRESSURE INCREASED 5 0.0000
985 PRURITUS 12 0.0000
986 ABDOMINAL PAIN UPPER 6 0.0000
987 ASTHMA 3 0.0000
988 BLOOD GLUCOSE INCREASED 5 0.0000
989 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
990 DRUG DOSE OMISSION 3 0.0000